GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 59 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $801,312 | +32.0% | 417,350 | -1.0% | 0.04% | +28.1% |
| Q2 2023 | $607,176 | -32.4% | 421,650 | -1.3% | 0.03% | -41.8% |
| Q1 2023 | $897,540 | +82.7% | 427,400 | -1.7% | 0.06% | +83.3% |
| Q4 2022 | $491,324 | -32.2% | 434,800 | -2.3% | 0.03% | -40.0% |
| Q3 2022 | $725,000 | +15.8% | 445,200 | -6.9% | 0.05% | +61.3% |
| Q2 2022 | $626,000 | -18.1% | 478,067 | +0.7% | 0.03% | -6.1% |
| Q1 2022 | $764,000 | -23.2% | 474,767 | -1.2% | 0.03% | -13.2% |
| Q4 2021 | $995,000 | -46.7% | 480,767 | -2.2% | 0.04% | -47.2% |
| Q3 2021 | $1,867,000 | +19.7% | 491,367 | -0.2% | 0.07% | +18.0% |
| Q2 2021 | $1,560,000 | -31.0% | 492,267 | -3.8% | 0.06% | -3.2% |
| Q1 2021 | $2,261,000 | +135.3% | 511,606 | +5.4% | 0.06% | +61.5% |
| Q4 2020 | $961,000 | +851.5% | 485,606 | +1211.8% | 0.04% | +680.0% |
| Q3 2020 | $101,000 | -6.5% | 37,017 | 0.0% | 0.01% | -16.7% |
| Q2 2020 | $108,000 | +35.0% | 37,017 | -11.3% | 0.01% | +20.0% |
| Q1 2020 | $80,000 | -36.5% | 41,750 | -4.6% | 0.01% | -28.6% |
| Q4 2019 | $126,000 | -21.2% | 43,750 | -0.9% | 0.01% | -30.0% |
| Q3 2019 | $160,000 | -27.3% | 44,150 | -16.9% | 0.01% | -28.6% |
| Q2 2019 | $220,000 | -22.5% | 53,150 | -4.5% | 0.01% | -26.3% |
| Q1 2019 | $284,000 | +26.8% | 55,650 | -6.7% | 0.02% | +11.8% |
| Q4 2018 | $224,000 | -37.4% | 59,650 | 0.0% | 0.02% | -29.2% |
| Q3 2018 | $358,000 | +359.0% | 59,650 | +383.0% | 0.02% | +300.0% |
| Q2 2018 | $78,000 | -60.2% | 12,350 | -70.2% | 0.01% | -64.7% |
| Q1 2018 | $196,000 | -20.0% | 41,390 | -43.7% | 0.02% | -22.7% |
| Q4 2017 | $245,000 | +67.8% | 73,485 | +7.1% | 0.02% | +46.7% |
| Q3 2017 | $146,000 | -2.0% | 68,612 | +13.2% | 0.02% | 0.0% |
| Q2 2017 | $149,000 | +14.6% | 60,612 | +7.1% | 0.02% | +7.1% |
| Q1 2017 | $130,000 | +154.9% | 56,612 | +7.6% | 0.01% | +100.0% |
| Q4 2016 | $51,000 | -10.5% | 52,612 | +3.5% | 0.01% | -12.5% |
| Q3 2016 | $57,000 | -26.0% | 50,812 | 0.0% | 0.01% | -27.3% |
| Q2 2016 | $77,000 | +5.5% | 50,812 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $73,000 | – | 50,812 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 129,488 | $248,617 | 0.07% |
| Geneos Wealth Management Inc. | 417,350 | $801,312 | 0.04% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $23,040 | 0.02% |
| RETIREMENT GUYS FORMULA LLC | 11,500 | $22,080 | 0.02% |
| Vivaldi Capital Management LP | 19,261 | $36,981 | 0.01% |
| OSAIC HOLDINGS, INC. | 3,275,192 | $6,288,345 | 0.01% |
| Traynor Capital Management, Inc. | 34,707 | $66,638 | 0.01% |
| Atria Wealth Solutions, Inc. | 259,800 | $498,816 | 0.01% |
| BARRETT & COMPANY, INC. | 4,984 | $9,569 | 0.01% |
| Wealthspire Advisors, LLC | 183,862 | $353,016 | 0.01% |